Thx Turbo, Unfortunately that doesn’t clear things up for me. Did they post up them as Ph1 because NEU has done the required animal and Ph1 testing for 2591?
As Jon said recently PWS is a crowded space! Without going deeply down that rabbit hole, ACAD is looking skinny to me at this point.
If NEU wasn’t the target he had in mind when ACAD CEO referred to new drugs that would require a lot of capital. At this point in time I can’t see ACAD having the grunt required to do any new deals with NEU.
ACAD has a considerable amount of upcoming expenditure just paying NEU the milestones of $250M and later $500m. Unless they can raise 3 x their current market cap , they can’t afford to play.
So his comments indicate he’s got a plan. I wonder what it is?
NEU Price at posting:
$19.02 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)